Copyright Reports & Markets. All rights reserved.

Global Hyperthermia Therapy for Cancer Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hyperthermia Therapy for Cancer Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Superficial Hyperthermia
    • 1.3.3 Deep Regional Hyperthermia
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hyperthermia Therapy for Cancer Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Breast Cancer
    • 1.4.3 Cervical Cancer
    • 1.4.4 Soft Tissue Sarcoma
    • 1.4.5 Melanoma
    • 1.4.6 Others
  • 1.5 Global Hyperthermia Therapy for Cancer Market Size & Forecast
    • 1.5.1 Global Hyperthermia Therapy for Cancer Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Hyperthermia Therapy for Cancer Sales Quantity (2021-2032)
    • 1.5.3 Global Hyperthermia Therapy for Cancer Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pyrexar Medical
    • 2.1.1 Pyrexar Medical Details
    • 2.1.2 Pyrexar Medical Major Business
    • 2.1.3 Pyrexar Medical Hyperthermia Therapy for Cancer Product and Services
    • 2.1.4 Pyrexar Medical Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pyrexar Medical Recent Developments/Updates
  • 2.2 Oncotherm
    • 2.2.1 Oncotherm Details
    • 2.2.2 Oncotherm Major Business
    • 2.2.3 Oncotherm Hyperthermia Therapy for Cancer Product and Services
    • 2.2.4 Oncotherm Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Oncotherm Recent Developments/Updates
  • 2.3 Andromedic
    • 2.3.1 Andromedic Details
    • 2.3.2 Andromedic Major Business
    • 2.3.3 Andromedic Hyperthermia Therapy for Cancer Product and Services
    • 2.3.4 Andromedic Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Andromedic Recent Developments/Updates
  • 2.4 Yamamoto Vinita
    • 2.4.1 Yamamoto Vinita Details
    • 2.4.2 Yamamoto Vinita Major Business
    • 2.4.3 Yamamoto Vinita Hyperthermia Therapy for Cancer Product and Services
    • 2.4.4 Yamamoto Vinita Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Yamamoto Vinita Recent Developments/Updates
  • 2.5 Med-Logix
    • 2.5.1 Med-Logix Details
    • 2.5.2 Med-Logix Major Business
    • 2.5.3 Med-Logix Hyperthermia Therapy for Cancer Product and Services
    • 2.5.4 Med-Logix Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Med-Logix Recent Developments/Updates
  • 2.6 Thermofield
    • 2.6.1 Thermofield Details
    • 2.6.2 Thermofield Major Business
    • 2.6.3 Thermofield Hyperthermia Therapy for Cancer Product and Services
    • 2.6.4 Thermofield Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Thermofield Recent Developments/Updates
  • 2.7 Celsius42
    • 2.7.1 Celsius42 Details
    • 2.7.2 Celsius42 Major Business
    • 2.7.3 Celsius42 Hyperthermia Therapy for Cancer Product and Services
    • 2.7.4 Celsius42 Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Celsius42 Recent Developments/Updates
  • 2.8 Dongseo Medicare
    • 2.8.1 Dongseo Medicare Details
    • 2.8.2 Dongseo Medicare Major Business
    • 2.8.3 Dongseo Medicare Hyperthermia Therapy for Cancer Product and Services
    • 2.8.4 Dongseo Medicare Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Dongseo Medicare Recent Developments/Updates
  • 2.9 ThermaSolutions
    • 2.9.1 ThermaSolutions Details
    • 2.9.2 ThermaSolutions Major Business
    • 2.9.3 ThermaSolutions Hyperthermia Therapy for Cancer Product and Services
    • 2.9.4 ThermaSolutions Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 ThermaSolutions Recent Developments/Updates
  • 2.10 Verthermia
    • 2.10.1 Verthermia Details
    • 2.10.2 Verthermia Major Business
    • 2.10.3 Verthermia Hyperthermia Therapy for Cancer Product and Services
    • 2.10.4 Verthermia Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Verthermia Recent Developments/Updates
  • 2.11 Combat Medical
    • 2.11.1 Combat Medical Details
    • 2.11.2 Combat Medical Major Business
    • 2.11.3 Combat Medical Hyperthermia Therapy for Cancer Product and Services
    • 2.11.4 Combat Medical Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Combat Medical Recent Developments/Updates
  • 2.12 Hydrosun
    • 2.12.1 Hydrosun Details
    • 2.12.2 Hydrosun Major Business
    • 2.12.3 Hydrosun Hyperthermia Therapy for Cancer Product and Services
    • 2.12.4 Hydrosun Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Hydrosun Recent Developments/Updates
  • 2.13 RanD Biotech
    • 2.13.1 RanD Biotech Details
    • 2.13.2 RanD Biotech Major Business
    • 2.13.3 RanD Biotech Hyperthermia Therapy for Cancer Product and Services
    • 2.13.4 RanD Biotech Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 RanD Biotech Recent Developments/Updates
  • 2.14 Shenzhen ET Medical Technology
    • 2.14.1 Shenzhen ET Medical Technology Details
    • 2.14.2 Shenzhen ET Medical Technology Major Business
    • 2.14.3 Shenzhen ET Medical Technology Hyperthermia Therapy for Cancer Product and Services
    • 2.14.4 Shenzhen ET Medical Technology Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Shenzhen ET Medical Technology Recent Developments/Updates
  • 2.15 Jiangsu Nova Medical Equipment
    • 2.15.1 Jiangsu Nova Medical Equipment Details
    • 2.15.2 Jiangsu Nova Medical Equipment Major Business
    • 2.15.3 Jiangsu Nova Medical Equipment Hyperthermia Therapy for Cancer Product and Services
    • 2.15.4 Jiangsu Nova Medical Equipment Hyperthermia Therapy for Cancer Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Jiangsu Nova Medical Equipment Recent Developments/Updates

3 Competitive Environment: Hyperthermia Therapy for Cancer by Manufacturer

  • 3.1 Global Hyperthermia Therapy for Cancer Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Hyperthermia Therapy for Cancer Revenue by Manufacturer (2021-2026)
  • 3.3 Global Hyperthermia Therapy for Cancer Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Hyperthermia Therapy for Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Hyperthermia Therapy for Cancer Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Hyperthermia Therapy for Cancer Manufacturer Market Share in 2025
  • 3.5 Hyperthermia Therapy for Cancer Market: Overall Company Footprint Analysis
    • 3.5.1 Hyperthermia Therapy for Cancer Market: Region Footprint
    • 3.5.2 Hyperthermia Therapy for Cancer Market: Company Product Type Footprint
    • 3.5.3 Hyperthermia Therapy for Cancer Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hyperthermia Therapy for Cancer Market Size by Region
    • 4.1.1 Global Hyperthermia Therapy for Cancer Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Hyperthermia Therapy for Cancer Consumption Value by Region (2021-2032)
    • 4.1.3 Global Hyperthermia Therapy for Cancer Average Price by Region (2021-2032)
  • 4.2 North America Hyperthermia Therapy for Cancer Consumption Value (2021-2032)
  • 4.3 Europe Hyperthermia Therapy for Cancer Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Hyperthermia Therapy for Cancer Consumption Value (2021-2032)
  • 4.5 South America Hyperthermia Therapy for Cancer Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Hyperthermia Therapy for Cancer Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Hyperthermia Therapy for Cancer Sales Quantity by Type (2021-2032)
  • 5.2 Global Hyperthermia Therapy for Cancer Consumption Value by Type (2021-2032)
  • 5.3 Global Hyperthermia Therapy for Cancer Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Hyperthermia Therapy for Cancer Sales Quantity by Application (2021-2032)
  • 6.2 Global Hyperthermia Therapy for Cancer Consumption Value by Application (2021-2032)
  • 6.3 Global Hyperthermia Therapy for Cancer Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Hyperthermia Therapy for Cancer Sales Quantity by Type (2021-2032)
  • 7.2 North America Hyperthermia Therapy for Cancer Sales Quantity by Application (2021-2032)
  • 7.3 North America Hyperthermia Therapy for Cancer Market Size by Country
    • 7.3.1 North America Hyperthermia Therapy for Cancer Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Hyperthermia Therapy for Cancer Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Hyperthermia Therapy for Cancer Sales Quantity by Type (2021-2032)
  • 8.2 Europe Hyperthermia Therapy for Cancer Sales Quantity by Application (2021-2032)
  • 8.3 Europe Hyperthermia Therapy for Cancer Market Size by Country
    • 8.3.1 Europe Hyperthermia Therapy for Cancer Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Hyperthermia Therapy for Cancer Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hyperthermia Therapy for Cancer Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Hyperthermia Therapy for Cancer Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Hyperthermia Therapy for Cancer Market Size by Region
    • 9.3.1 Asia-Pacific Hyperthermia Therapy for Cancer Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Hyperthermia Therapy for Cancer Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Hyperthermia Therapy for Cancer Sales Quantity by Type (2021-2032)
  • 10.2 South America Hyperthermia Therapy for Cancer Sales Quantity by Application (2021-2032)
  • 10.3 South America Hyperthermia Therapy for Cancer Market Size by Country
    • 10.3.1 South America Hyperthermia Therapy for Cancer Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Hyperthermia Therapy for Cancer Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hyperthermia Therapy for Cancer Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Hyperthermia Therapy for Cancer Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Hyperthermia Therapy for Cancer Market Size by Country
    • 11.3.1 Middle East & Africa Hyperthermia Therapy for Cancer Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Hyperthermia Therapy for Cancer Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Hyperthermia Therapy for Cancer Market Drivers
  • 12.2 Hyperthermia Therapy for Cancer Market Restraints
  • 12.3 Hyperthermia Therapy for Cancer Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hyperthermia Therapy for Cancer and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hyperthermia Therapy for Cancer
  • 13.3 Hyperthermia Therapy for Cancer Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hyperthermia Therapy for Cancer Typical Distributors
  • 14.3 Hyperthermia Therapy for Cancer Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hyperthermia Therapy for Cancer market size was valued at US$ 462 million in 2025 and is forecast to a readjusted size of US$ 664 million by 2032 with a CAGR of 5.4% during review period.
    Hyperthermia therapy for cancer, also known as thermal therapy or thermotherapy, is a type of treatment in which body tissue is exposed to high temperatures (up to 113°F or 45°C) to damage and kill cancer cells. This approach can enhance the effectiveness of other treatments such as radiation therapy and chemotherapy. Hyperthermia is typically used to treat tumors located in specific parts of the body, such as the chest, liver, or limbs. The heat can be applied using various techniques, including external applicators, internal probes, or perfusion methods where heated substances are circulated through the body. The primary goal is to target cancer cells while minimizing damage to surrounding healthy tissue.
    The hyperthermia therapy for cancer market is witnessing growing interest due to its potential to enhance the effectiveness of conventional cancer treatments such as radiation and chemotherapy. As a non-invasive or minimally invasive technique, hyperthermia therapy appeals to both clinicians and patients seeking targeted therapeutic options with fewer systemic side effects. Technological advancements in thermal delivery systems and imaging-guided precision are further improving clinical outcomes and driving innovation. Although still considered an adjunct treatment in many oncology protocols, the increasing number of clinical studies and expanding awareness of its benefits suggest that hyperthermia therapy is poised to become a more integral component of comprehensive cancer care strategies in the coming years.
    This report is a detailed and comprehensive analysis for global Hyperthermia Therapy for Cancer market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hyperthermia Therapy for Cancer market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Hyperthermia Therapy for Cancer market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Hyperthermia Therapy for Cancer market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2021-2032
    Global Hyperthermia Therapy for Cancer market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hyperthermia Therapy for Cancer
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hyperthermia Therapy for Cancer market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pyrexar Medical, Oncotherm, Andromedic, Yamamoto Vinita, Med-Logix, Thermofield, Celsius42, Dongseo Medicare, ThermaSolutions, Verthermia, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hyperthermia Therapy for Cancer market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Superficial Hyperthermia
    Deep Regional Hyperthermia
    Market segment by Application
    Breast Cancer
    Cervical Cancer
    Soft Tissue Sarcoma
    Melanoma
    Others
    Major players covered
    Pyrexar Medical
    Oncotherm
    Andromedic
    Yamamoto Vinita
    Med-Logix
    Thermofield
    Celsius42
    Dongseo Medicare
    ThermaSolutions
    Verthermia
    Combat Medical
    Hydrosun
    RanD Biotech
    Shenzhen ET Medical Technology
    Jiangsu Nova Medical Equipment
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hyperthermia Therapy for Cancer product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hyperthermia Therapy for Cancer, with price, sales quantity, revenue, and global market share of Hyperthermia Therapy for Cancer from 2021 to 2026.
    Chapter 3, the Hyperthermia Therapy for Cancer competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hyperthermia Therapy for Cancer breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Hyperthermia Therapy for Cancer market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hyperthermia Therapy for Cancer.
    Chapter 14 and 15, to describe Hyperthermia Therapy for Cancer sales channel, distributors, customers, research findings and conclusion.

    Buy now